Big news from the medical science community regarding two drugs that may be able to modestly slow the progression of Alzheimer’s disease for some patients.
The two drugs are Leqembi (lecanemab) and Kisunla (donanemab), and someday they might prevent cognitive decline entirely in people whose brains show signs of disease, but who don’t yet have symptoms.
AARP has a very timely and informative piece on the new drugs and what it may mean for Alzheimer’s treatment now and in the future.
To read the story, CLICK HERE.
